Genu Recurvatum
Conditions
Keywords
genu recurvatum, Cerebral Palsy, Universal Exercise Unit, Rebound Therapy
Brief summary
to investigate and compare between effectiveness of Universal Exercise Unit and Rebound Therapy on genu recurvatum, muscle strength, balance, functional mobility and quality of life in spastic cerebral palsy children
Detailed description
Children will be equally assigned into three groups using simple randomization, control group, study group (A) and study group (B). Each group will consist of 20 children with spastic CP to overcome any drop out may occur. Control group: Children in this group will receive a traditional physical therapy program. Study group (A): Children in this group will receive a traditional physical therapy program in addition to universal exercise unit program. Study group (B): Children in this group will receive the same traditional physical therapy program in addition to rebound therapy. Evaluation will be carried out for each child individually before and after 3 months of treatment.
Interventions
universal exercise unit (UEU) for study groip (A)
rebound therpay for study group (B)
traditional physical therapy program for contrl group
Sponsors
Study design
Masking description
Participants will be assigned randomly into three groups of equal number (control group, study group A and study group B ) the randomization will be performed by simple randomization. Assessors will be blinded to the groups of the subjects.
Eligibility
Inclusion criteria
* -Children with spastic CP both hemiplegic and diplegic. * Their ages will be ranged from 5-7 years old. * They will have mild spasticity (grade 1 and 1+) according to Modified Ashworth scale . * They will be in level I and II according to gross motor function classification system (GMFCS) . * They will be able to understand orders given to them.
Exclusion criteria
* Subjects will be excluded if they have the following: 1. Visual or hearing impairment. 2. Severe limb deformities as structural genurecurvatum. 3. Surgical interference in the lower limbs for the last 6 months. 4. Botulinum toxin injection of the spastic lower limb muscles during the last six months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| degree of genu recurvatum | 10 minutes | degree of genu recurvatum will be measured by Radiological X-Ray |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| muscle power | 2 minutes | muscle power will be assessed by using Lafayette Manual Muscle Tester |
| balance | 20 minutes | Balance will be assessed by Pediatric Balance Scale |
| functional mobility | 20 minutes | Functional mobility will be assessed by Mobility Questionnaire (Mob Quest 28 ) |
| Quality of child life | 20 minutes administration for each child | Quality of life will be assessed by using Pediatric Quality of Life Inventory (PedsQL) scale |
Countries
Egypt